These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5122593)

  • 1. [Inhibition capacity of serum for proteolytic enzymes during massive hemorrhages and in the pathogenesis of shock].
    Duck HJ; Ebeling K; Wagner J
    Z Gesamte Inn Med; 1971 Jun; 26(12):Suppl:147-51. PubMed ID: 5122593
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inhibitory capacity of the serum toward proteolytic enzymes during massive hemorrhage and in the pathogenesis of shock].
    Duck HJ; Ebeling K; Wagner J
    Z Gesamte Inn Med; 1971 Jun; 26(12):Suppl:147-51. PubMed ID: 5570303
    [No Abstract]   [Full Text] [Related]  

  • 3. [Inhibition capacity for proteolytic enzymes in umbilical cord venous blood following normal and complicated labor].
    Ebeling K; Duck HJ; Wagner J
    Zentralbl Gynakol; 1972 May; 94(18):583-8. PubMed ID: 5043996
    [No Abstract]   [Full Text] [Related]  

  • 4. [Differential diagnosis and therapy of hemorrhages in shock and collaps].
    Perlick E
    Z Gesamte Inn Med; 1971 Jun; 26(12):Suppl:145-7 f. PubMed ID: 5122592
    [No Abstract]   [Full Text] [Related]  

  • 5. [Characterization of shock sensitivity in experimental hemorrhagic shock (5,3 and 8,0 kPa) by determining kallikrein, kallikreinogen, non-specific proteases and inhibitor capacity of blood plasma].
    Kühne H; Lehmann B; Taucher M; Scheuch DW
    Z Med Lab Diagn; 1983; 24(3):123-8. PubMed ID: 6351457
    [No Abstract]   [Full Text] [Related]  

  • 6. [Proteolytic serum activity in traumatic shock].
    Kazueva TV; Kovrizhnykh EE; Tsibin IuN
    Vestn Khir Im I I Grek; 1971 Feb; 106(2):40-2. PubMed ID: 5117962
    [No Abstract]   [Full Text] [Related]  

  • 7. [Kallikrein activity and non-specific esterolytic activity of proteases in experimental hemorrhagic shock of varying duration and depth].
    Kühne H; Scheuch DW
    Z Med Lab Diagn; 1979 Feb; 20(1):20-3. PubMed ID: 452638
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on the antiproteolytic serum capacity in urticaria pigmentosa].
    Buchholz W; Duck HJ; Barth J
    Dermatol Monatsschr; 1972 Feb; 158(2):116-21. PubMed ID: 4260840
    [No Abstract]   [Full Text] [Related]  

  • 9. [Differential diagnosis and therapy of hemorrhagic shock and collapse].
    Perlick E
    Z Gesamte Inn Med; 1971 Jun; 26(12):145-7 concl. PubMed ID: 5570295
    [No Abstract]   [Full Text] [Related]  

  • 10. Proteolytic enzymes and biological inhibitors. I. Comparison between the Kunitz method and the agar gel casein precipitating reaction for determination of the activity of some commercial proteolytic enzymes and inhibitors.
    Fossum K
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1970; 78(3):350-62. PubMed ID: 4990979
    [No Abstract]   [Full Text] [Related]  

  • 11. [Behavior of plasma kallikrein and protease activities in hemorrhagic shock of the dog].
    Kühne H; Scheuch DW
    Z Med Lab Diagn; 1977 Jun; 18(3):169-76. PubMed ID: 899160
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hemostasis disorders in cancer patients with massive intraoperative blood loss].
    Madzhuga AV; Somonova OV; Elizarova AL; Sviridova SP; Mazurina OG; Kashiia ShR
    Anesteziol Reanimatol; 2001; (5):50-2. PubMed ID: 11757302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Differential diagnosis and therapy of hemorrhages in shock and collapse].
    Perlick E
    Z Gesamte Inn Med; 1971 Jun; 26(11):Suppl:141-4 c. PubMed ID: 5564660
    [No Abstract]   [Full Text] [Related]  

  • 14. [Proteolytic and antitrypsin activity of blood serum in myocardial infarct].
    Lisovskiĭ VA; Trofimov GA; Minin PP
    Klin Med (Mosk); 1978 Jan; 56(1):78-81. PubMed ID: 633805
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antiproteolytic capacity of the serum in diverse forms of urticaria].
    Duck HJ; Barth J; Wagner J
    Dermatol Monatsschr; 1971 Jul; 157(7):491-9. PubMed ID: 5116598
    [No Abstract]   [Full Text] [Related]  

  • 16. [Determination of the antitrypsin and proteolytic activity in human serum].
    Kudrewicz-Hubicka Z; Majewska S
    Pol Tyg Lek; 1970 Jul; 25(29):1076-8. PubMed ID: 5449809
    [No Abstract]   [Full Text] [Related]  

  • 17. [Kallikrein activity and the inhibitory capacity of the blood plasma in experimental hemorrhagic shock in dogs].
    Kühne H; Lehmann B; Scheuch DW
    Khirurgiia (Sofiia); 1979; 32(4):273-8. PubMed ID: 316041
    [No Abstract]   [Full Text] [Related]  

  • 18. [Diagnostic and therapy of acute coagulation disorders in hemorrhagic shock].
    Wüst T
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 Nov; 36 Suppl 2():S144-5. PubMed ID: 11753725
    [No Abstract]   [Full Text] [Related]  

  • 19. [Proteolytic activity and content of trypsin inhibitor in the blood serum of patients with leukemia].
    Trusova NF; Tsigikian TA; Shaternikov VA
    Lab Delo; 1973; 9():546-9. PubMed ID: 4128707
    [No Abstract]   [Full Text] [Related]  

  • 20. [Protein catabolism and tourniquet shock: the role of proteolytic enzymes].
    Hörl M; Hörl WH; Heidland A
    Chirurg; 1982 Apr; 53(4):253-7. PubMed ID: 6177476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.